188 related articles for article (PubMed ID: 21769489)
1. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis.
Moon KW; Song R; Kim JH; Lee EY; Lee EB; Song YW
Rheumatol Int; 2012 Aug; 32(8):2465-70. PubMed ID: 21769489
[TBL] [Abstract][Full Text] [Related]
2. Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial.
Merkel PA; Silliman NP; Denton CP; Furst DE; Khanna D; Emery P; Hsu VM; Streisand JB; Polisson RP; Akesson A; Coppock J; van den Hoogen F; Herrick A; Mayes MD; Veale D; Seibold JR; Black CM; Korn JH; ;
Arthritis Rheum; 2008 May; 59(5):699-705. PubMed ID: 18438905
[TBL] [Abstract][Full Text] [Related]
3. Impact of EUSTAR standardized training on accuracy of modified Rodnan skin score in patients with systemic sclerosis.
Park JW; Ahn GY; Kim JW; Park ES; Kang JH; Chang SH; Choi IA; Yoo SJ; Park JK; Shin K; Park YB; Jun JB; Czirják L; Allanore Y; Matucci-Cerinic M; Lee EB
Int J Rheum Dis; 2019 Jan; 22(1):96-102. PubMed ID: 30398033
[TBL] [Abstract][Full Text] [Related]
4. A stretchable hardness sensor for the assessment of skin disease in systemic sclerosis.
Wang X; Liu M; Ye T; Huang J; Xu X; Li M; Zhao X; Lu H; Yang J
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37996124
[TBL] [Abstract][Full Text] [Related]
5. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study.
Peytrignet S; Denton CP; Lunt M; Hesselstrand R; Mouthon L; Silman A; Pan X; Brown E; Czirják L; Distler JHW; Distler O; Fligelstone K; Gregory WJ; Ochiel R; Vonk M; Ancuta C; Ong VH; Farge D; Hudson M; Matucci-Cerinic M; Balbir-Gurman A; Midtvedt Ø; Jordan AC; Stevens W; Moinzadeh P; Hall FC; Agard C; Anderson ME; Diot E; Madhok R; Akil M; Buch MH; Chung L; Damjanov N; Gunawardena H; Lanyon P; Ahmad Y; Chakravarty K; Jacobsen S; MacGregor AJ; McHugh N; Müller-Ladner U; Riemekasten G; Becker M; Roddy J; Carreira PE; Fauchais AL; Hachulla E; Hamilton J; Inanç M; McLaren JS; van Laar JM; Pathare S; Proudman S; Rudin A; Sahhar J; Coppere B; Serratrice C; Sheeran T; Veale DJ; Grange C; Trad GS; Herrick AL
Rheumatology (Oxford); 2018 Feb; 57(2):370-381. PubMed ID: 29207002
[TBL] [Abstract][Full Text] [Related]
6. Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study.
Juhl P; Vinderslev Iversen L; Karlsmark T; Asser Karsdal M; Bay-Jensen AC; Mogensen M; Siebuhr AS
Biomarkers; 2019 Jun; 24(4):373-378. PubMed ID: 30821519
[No Abstract] [Full Text] [Related]
7. High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.
Wannarong T; Muangchan C
Rheumatol Int; 2018 Dec; 38(12):2279-2288. PubMed ID: 30206672
[TBL] [Abstract][Full Text] [Related]
8. Durometry for the assessment of skin disease in systemic sclerosis.
Kissin EY; Schiller AM; Gelbard RB; Anderson JJ; Falanga V; Simms RW; Korn JH; Merkel PA
Arthritis Rheum; 2006 Aug; 55(4):603-9. PubMed ID: 16874783
[TBL] [Abstract][Full Text] [Related]
9. Changes in disability and their relationship with skin thickening, in diffuse and limited cutaneous systemic sclerosis: a retrospective cohort study.
Peytrignet S; Manning J; Wragg E; Moore T; Samaranayaka M; Dinsdale G; Herrick AL
Scand J Rheumatol; 2019 May; 48(3):230-234. PubMed ID: 30394164
[TBL] [Abstract][Full Text] [Related]
10. Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients.
Ruaro B; Pizzorni C; Paolino S; Smith V; Ghio M; Casabella A; Alessandri E; Patané M; Sulli A; Cutolo M
Microvasc Res; 2019 Sep; 125():103874. PubMed ID: 30974112
[TBL] [Abstract][Full Text] [Related]
11. Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis.
Sulli A; Ruaro B; Smith V; Paolino S; Pizzorni C; Pesce G; Cutolo M
Arthritis Res Ther; 2017 Mar; 19(1):61. PubMed ID: 28320447
[TBL] [Abstract][Full Text] [Related]
12. Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
Khanna D; Clements PJ; Volkmann ER; Wilhalme H; Tseng CH; Furst DE; Roth MD; Distler O; Tashkin DP
Arthritis Res Ther; 2019 Jan; 21(1):23. PubMed ID: 30651141
[TBL] [Abstract][Full Text] [Related]
13. Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity.
Zheng B; Nevskaya T; Baxter CA; Ramey DR; Pope JE; Baron M;
Rheumatology (Oxford); 2020 Feb; 59(2):398-406. PubMed ID: 31359048
[TBL] [Abstract][Full Text] [Related]
14. Nailfold capillaroscopy by digital microscope in an Indian population with systemic sclerosis.
Bhakuni DS; Vasdev V; Garg MK; Narayanan K; Jain R; Mullick G
Int J Rheum Dis; 2012 Feb; 15(1):95-101. PubMed ID: 22324952
[TBL] [Abstract][Full Text] [Related]
15. Durometry as an alternative tool to the modified Rodnan's skin score in the assessment of diffuse systemic sclerosis patients: a cross-sectional study.
de Oliveira MFC; Leopoldo VC; Pereira KRC; de Moraes DA; Dias JBE; Gonçalves MS; Ramalho LNZ; Dos Santos BN; de Oliveira MC; Silveira RCCP
Adv Rheumatol; 2020 Sep; 60(1):48. PubMed ID: 32958068
[TBL] [Abstract][Full Text] [Related]
16. The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma.
Sultan N; Pope JE; Clements PJ;
Rheumatology (Oxford); 2004 Apr; 43(4):472-8. PubMed ID: 14679295
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials.
Kaldas M; Khanna PP; Furst DE; Clements PJ; Kee Wong W; Seibold JR; Postlethwaite AE; Khanna D;
Rheumatology (Oxford); 2009 Sep; 48(9):1143-6. PubMed ID: 19605370
[TBL] [Abstract][Full Text] [Related]
18. Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.
Nevskaya T; Zheng B; Baxter CA; Ramey DR; Pope JE; Baron M;
Rheumatology (Oxford); 2020 Jul; 59(7):1715-1724. PubMed ID: 31774531
[TBL] [Abstract][Full Text] [Related]
19. Reliability and Validity of the Tender and Swollen Joint Counts and the Modified Rodnan Skin Score in Early Diffuse Cutaneous Systemic Sclerosis: Analysis from the Prospective Registry of Early Systemic Sclerosis Cohort.
Gordon JK; Girish G; Berrocal VJ; Zhang M; Hatzis C; Assassi S; Bernstein EJ; Domsic RT; Hant FN; Hinchcliff M; Schiopu E; Steen VD; Frech TM; Khanna D
J Rheumatol; 2017 Jun; 44(6):791-794. PubMed ID: 28298560
[TBL] [Abstract][Full Text] [Related]
20. Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis.
Wiese AB; Berrocal VJ; Furst DE; Seibold JR; Merkel PA; Mayes MD; Khanna D
Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1731-9. PubMed ID: 24692361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
